Bio-Connect
WB analysis of A549 lysate (35ug) using Cystatin B antibody [2F1] at a dilution of 1:1,000.
WB analysis of A549 lysate (35ug) using Cystatin B antibody [2F1] at a dilution of 1:1,000.
WB analysis of A549 lysate (35ug) using Cystatin B antibody [2F1] at a dilution of 1:1,000.

Cystatin B antibody [2F1]

GTX53707
GeneTex
ApplicationsWestern Blot, ELISA
Product group Antibodies
ReactivityHuman
TargetCSTB
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    Cystatin B antibody [2F1]
  • Delivery Days Customer
    9
  • Application Supplier Note
    The antibody has been tested by ELISA and Western blot analysis to assure specificity and reactivity. Since application varies, however, each investigation should be titrated by the reagent to obtain optimal results. Recommended dilution range for Western blot analysis is 1:1,000~ 2,000. Recommended starting dilution is 1:1,000.
  • Applications
    Western Blot, ELISA
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    2F1
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID1476
  • Target name
    CSTB
  • Target description
    cystatin B
  • Target synonyms
    CPI-B; CST6; cystatin B (stefin B); cystatin-B; epididymis secretory sperm binding protein; EPM1; EPM1A; liver thiol proteinase inhibitor; PME; STFB; ULD
  • Host
    Mouse
  • Isotype
    IgG2b
  • Protein IDP04080
  • Protein Name
    Cystatin-B
  • Scientific Description
    The cystatin superfamily encompasses proteins that contain multiple cystatin-like sequences. Some of the members are active cysteine protease inhibitors, while others have lost or perhaps never acquired this inhibitory activity. There are three inhibitory families in the superfamily, including the type 1 cystatins (stefins), type 2 cystatins and kininogens. This gene encodes a stefin that functions as an intracellular thiol protease inhibitor. The protein is able to form a dimer stabilized by noncovalent forces, inhibiting papain and cathepsins l, h and b. The protein is thought to play a role in protecting against the proteases leaking from lysosomes. Evidence indicates that mutations in this gene are responsible for the primary defects in patients with progressive myoclonic epilepsy (EPM1). One type of mutation responsible for EPM1 is the expansion in the promoter region of this gene of a CCCCGCCCCGCG repeat from 2-3 copies to 30-78 copies. [provided by RefSeq, Jul 2016]
  • Reactivity
    Human
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203